|
|
|
|
| LEADER |
00739nam a22002171 4500 |
| 001 |
000192521 |
| 003 |
UPRA |
| 005 |
19951020210659.0 |
| 007 |
ta |
| 008 |
951020s1942 dfm 0 spa d |
| 035 |
|
|
|a 221500
|
| 040 |
|
|
|a mxbn
|b spa
|c upra
|
| 082 |
0 |
4 |
|a 615.31
|b SUL.a.
|
| 245 |
0 |
4 |
|a Las sulfanilamidas :
|b acción, indicaciones, modo de empleo
|
| 260 |
|
|
|a México :
|b Sugestiones,
|c 1942
|
| 300 |
|
|
|a 69 p. ;
|c 19 cm.
|
| 440 |
|
0 |
|a Actualidad médica
|
| 650 |
|
8 |
|a Sulfanilamida.
|
| 852 |
|
|
|l BNM01
|l BNM01
|m LIB
|1 GENE
|a Colección General (BN)
|2 G
|b Colección General
|3 615.31 SUL.a.
|h Piso 3
|6 65-043951
|5 65-043951
|4 Inventariado 2019 por inves
|8 20040528
|e 00
|f 05
|f En servicio
|
| 900 |
|
|
|a UPRA
|b SBO
|
| 905 |
|
|
|a GENE
|b G
|
